News

Vesicle-based vaccine adjuvant improves protection against influenza viruses, study shows
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
News-Medical.Net on MSN1d
Mature dendritic cell vesicles enhance influenza vaccine effectiveness
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Technology Networks1d
Flu Vaccine Adjuvant Improves Cross Protection Against Influenza Viruses
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Infectious Disease Advisor8h
Multicomponent Vaccine for COVID-19, Influenza Shows Promise in Phase 3 Trial
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
Moderna's mRNA Flu Vaccine Outperforms Standard Shots
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
Moderna reports effective results from influenza vaccine trial
Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.
Kennedy’s New Advisers Rescind Recommendations for Some Flu Vaccines
Dr. Levi and Vicky Pebsworth, a nurse affiliated with an anti-vaccine group, voted against recommending clesrovimab; the ...
CDC vaccine advisory panel recommends against flu vaccines containing thimerosal
The CDC's vaccine advisory committee voted to recommend annual flu vaccines but against flu shots containing the preservative ...